Cargando…
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study
Objective: To evaluate the efficacy and safety of dasotraline for treatment of ADHD in children. Method: Children (ages 6-12 years; N = 112) with ADHD were randomized, double-blind, to 14 days of once-daily evening doses of dasotraline 4 mg or placebo. ADHD symptom severity was measured at baseline...
Autores principales: | Wigal, Sharon B., Hopkins, Seth C., Koblan, Kenneth S., Childress, Ann, Kent, Justine M., Tsai, Joyce, Hsu, Jay, Loebel, Antony, Goldman, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129465/ https://www.ncbi.nlm.nih.gov/pubmed/31375051 http://dx.doi.org/10.1177/1087054719864644 |
Ejemplares similares
-
Pharmacokinetics and Exposure-Response Relationships of Dasotraline in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
por: Hopkins, Seth C., et al.
Publicado: (2015) -
Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
por: Koblan, Kenneth S, et al.
Publicado: (2015) -
Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial
por: Grilo, Carlos M., et al.
Publicado: (2021) -
The rate of dasotraline brain entry is slow following intravenous administration
por: Lew, Robert, et al.
Publicado: (2020) -
Absorption, distribution, metabolism, and excretion of [(14)C]‐dasotraline in humans
por: Chen, Yu‐Luan, et al.
Publicado: (2016)